TIME 100 HEALTH-PIONEERS
The GLP-1 scientists, Akiko Iwasaki, Michael J. Fox, Hadiza Galadanci, Vivek Murthy +92 more
Jens Juul Holst, Joel Habener, Svetlana Mojsov, and Dan Drucker PAVING THE WAY FOR WEIGHT-LOSS DRUGS
If [GLP-1 drugs] show benefit for even half of these conditions, then that will be a tremendous win for people struggling with them.' -DAN DRUCKER
Newly powerful weight-loss drugs became the biggest story in health in the past year-and Jens Juul Holst, Joel Habener, Svetlana Mojsov, and Dan Drucker played pivotal roles in making those medications possible. The scientists conducted the early work, beginning in the 1970s, on glucagon-like peptides, or GLPs, that first transformed the treatment of diabetes and now that of obesity.
As with many groundbreaking medical developments, it was a group effort. Holst, at the University of Copenhagen, noticed that after intestinal surgery, patients' levels of insulin soared while their blood-sugar levels dropped; he attributed the changes to several gut-related hormones, including glucagon, which is made in the pancreas. Around the same time, an ocean and a continent away in Boston, Habener and Drucker worked with animals in the lab at Massachusetts General Hospital and identified new types of glucagon hormones that they called GLP-1 and GLP-2. Mojsov, a chemist two floors away, also independently identified the active portion of GLP-1, which is mimicked in the new weight-loss drugs as the key compound in Ozempic and Wegovy (made by Novo Nordisk) and one of two main compounds in Mounjaro and Zepbound (made by Eli Lilly). Mojsov produced large amounts of the peptide and developed antibodies to stick to them. The trio eventually collaborated on critical scientific papers that described the active part of GLP-1 in the guts of rats, and documented that increasing GLP-1 levels corresponded to increasing levels of insulin.
هذه القصة مأخوذة من طبعة May 13, 2024 من Time.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,500 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة May 13, 2024 من Time.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,500 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Documentary revisits ping-pong days of 1971
In 1971 the American table tennis player Glenn Cowan boarded the wrong bus during the world championships in Nagoya, Japan. He missed the U.S. team's bus and got on the next one, only to find himself on the Chinese team’s bus.
5 ways to swim safely this summer
THAT GLISTENING SWIMMING hole might look-and feelrefreshing on a sweltering day.
Scrambling To Survive
FILIPINO FISHING FAMILIES CONFRONT THE WORLD'S CHANGING RELATIONSHIP WITH THE SEA
Health Matters
AS CONGRESS EYES SWEEPING cuts to Medicaid, the health care program for low-income adults that serves about 20% of people living in the U.S., a new study has a sharp conclusion: cuts to Medicaid will cost lives.
Why are ‘100-year storms’ happening so often?
CLIMATE CHANGE IS LEADING NOT ONLY TO DROUGHTS, wildfires, and extreme weather. It's also leading to oxymorons—at least when it comes to what are known as 100-year storms, floods, and other events.
Mike Birbiglia The comedian on his fourth Netflix special The Good Life, the rise of right-wing comics, and being funny vs. being famous
What would you say people like about you?
Q&A With Diva Amo
The marine biologist working to protect our oceans from deep-sea mining
Sebastião Salgado
SEBASTIÃO SALGADO, 81, WHO DIED IN PARIS ON MAY 23, TOOK photographs that were too beautiful to look away from.
Approaching the end, with deliberate steps
STORIES ABOUT THE MEANING OF LIFE TEND to work at cross-purposes with the job of actually living it, particularly when they pedal hard to activate the tear ducts.
Valuing Our Oceans
It's time for a shift in economics
